Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer

Completed

• Conditions: Childhood Cancer

• Registration Number: NCT00579293
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

This study will compare two ways of having people respond to a questionnaire about health and emotional well-being: on a computer and with paper and pencil. We will see how long it takes using both methods. We will also ask you how you feel about using a computer to answer the questions.

Detailed Description

To determine feasibility of using the Computer Assisted Survivor Screening (CASS) as a routine screening measure for the survivor population. Specifically, to determine patient acceptance, time to completion, and burden associated with the CASS. To examine the potential utility of the CASS as a routine screening measure in the survivor population. To validate the CASS against the SCL-90-R screening measure. Calculate the sensitivity,specificity, positive and negative predictive values, diagnostic agreement and ROC curve of the CASS compared to the SCL-90. Determine the optimal cut-off scores to optimize agreement between the CASS and the SCL-90.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2004-08
• Study First Submitted: 2007-12-20
• Study First Submitted QC: 2007-12-20
• Study First Posted: 2007-12-24
• Status Verified: 2008-07
• Primary Completion: 2008-07
• Study Completion: 2008-07
• Last Update Submitted: 2008-07-24
• Last Update Posted: 2008-07-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Currently at least 18 years of age and not older than 49 years of age
• Diagnosed with first malignancy before the age of 22
• Completed all cancer treatment at least three years prior
• Able to complete the survey instruments in English
• Scheduled for a routine off-treatment follow-up oncology appointment
• Currently disease-free and not receiving any cancer treatment

Read More

Exclusion Criteria

• History of a central nervous system tumor
• A sensory or cognitive impairment that would interfere with completion of the survey
• Currently undergoing treatment by a psychiatrist or psychologist (ie., currently receiving psychotherapy and/or psychotropic medications, as per self-report)

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Memorial Sloan-Kettering Cancer Center; 🇺🇸 New York, New York, United States